Mauritius vs Yemen: Previously treated cases tested for RR-/MDR-TB
Mauritius
100.0%
in 2022
Yemen
100.0%
in 2024
Mauritius rank
1st
Yemen rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Mauritius
- Yemen
How they compare
Mauritius currently reports 100.0% against 100.0% in Yemen, a difference of 0.0%.
Across all 15 years both countries report, Mauritius has been ahead every year.
Mauritius ranks 1st and Yemen ranks 1st of 180 countries.
Mauritius has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mauritius | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 11.2% | 88.8% | Mauritius |
| 2010s | 95.0% | 21.5% | 73.5% | Mauritius |
| 2020s | 100.0% | 40.3% | 59.7% | Mauritius |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Mauritius or Yemen?
- Mauritius, at 100.0% against 100.0% in Yemen as of 2022.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Mauritius and Yemen?
- 0.0%, with Mauritius ahead.
- How many years of comparable data are there for Mauritius and Yemen?
- 15 years are reported by both, from 2006 to 2022.
- How do Mauritius and Yemen rank globally for previously treated cases tested for rr-/mdr-tb?
- Mauritius ranks 1st and Yemen ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.